Pyronaridine Protects against SARS-CoV-2 Infection in Mouse

Author:

Puhl Ana C.1ORCID,Gomes Giovanni F.2,Damasceno Samara2,Godoy Andre S.3,Noske Gabriela D.3,Nakamura Aline M.3,Gawriljuk Victor O.3,Fernandes Rafaela S.3,Monakhova Natalia4,Riabova Olga4,Lane Thomas R.1,Makarov Vadim4,Veras Flavio P.2,Batah Sabrina S.5,Fabro Alexandre T.5,Oliva Glaucius3,Cunha Fernando Q.2,Alves-Filho José C.2,Cunha Thiago M.2,Ekins Sean1ORCID

Affiliation:

1. Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina 27606, United States

2. Center for Research in Inflammatory Diseases (CRID), Ribeirao Preto Medical School, University of São Paulo, Avenida Bandeirantes, 3900, Ribeirao Preto 14049-900, São Paulo, Brazil

3. Institute of Physics of Sao Carlos, University of São Paulo, Av. Joao Dagnone, 1100 - Jardim Santa Angelina, Sao Carlos 13563-120, Brazil

4. Research Center of Biotechnology RAS, Leninsky prospect, 33, Building 2, 119071 Moscow, Russia

5. Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Avenida Bandeirantes, 3900, Ribeirao Preto 14049-900, São Paulo, Brazil

Funder

National Center for Complementary and Alternative Medicine

National Institute of Allergy and Infectious Diseases

Russian Foundation for Basic Research

Funda??o Amaz?nia Paraense de Amparo ? Pesquisa

Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo

National Institute of General Medical Sciences

Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Reference83 articles.

1. Author Correction: A new coronavirus associated with human respiratory disease in China

2. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

3. WHO Naming the coronavirus disease (COVID-2019) and the virus that causes it. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.

4. Novel coronavirus disease (COVID-19) pandemic: A recent mini review

5. SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3